Laryngopharyngeal Reflux - 20 Studies Found
Recruiting |
: Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy :
: Drug: dexlansoprazole dexlansoprazole 60 mg once daily for 3 months |
Recruiting |
: Laryngopharyngeal Reflux Before and After Cricopharyngeal Myotomy :
: 2013-06-14 :
|
Completed |
: Omeprazole 20 mg in Patients With Laryngopharyngeal reflux and Comorbid Chronic Rhinosinusitis :
: |
Enrolling by invitation |
: Assessing the Impacts of a UESAD on Laryngeal Symptoms and Salivary Pepsin : Laryngopharyngeal Reflux : 2015-09-16 : Device: UESAD Device designed to provide modest cricoid pressure to reduce reflux |
Enrolling by invitation |
: Predictive Value of Subjective and Objective Measurement Tools for Extraesophageal Reflux : Laryngopharyngeal Reflux : 2013-04-02 |
Completed |
: Treatment of Extraesophageal Reflux With the Reza Band UES Assist Device : Laryngopharyngeal Reflux : 2013-05-16 : Device: Reza Band UES Assist Device Device is worn by patient to reduce or eliminate laryngopharyngeal r |
Terminated |
: Anti-reflux Control to Decrease Post Tonsillectomy Pain :
: 2013-01-25 : Drug: Omeprazole The principal investigator will be contacted and will work with the research pharmacist |
Completed |
: Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux :
: 2006-09-05 :
|
Completed |
: Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment? :
: 2007-03-05 :
|
NOT_YET_RECRUITING |
: Lexiva for the Treatment of LPR : Laryngopharyngeal Reflux : 2024-11-21 : A repurposing approach, prospective, placebo-controlled clinical trial of Lexiva (used at the FDA approved, manufacturers recommended dose for HIV (1, |